SMTL ID : 6hr2.1 (1 other biounit)

Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:ElonginB

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.76 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x FWZ: (2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)

FWZ.1: 33 residues within 4Å: Chain A: V.36, F.37, Q.39, L.40, P.41, L.46, Y.49, V.57, D.58, L.84, N.87, A.88, F.91, N.92, L.93, I.98 Chain B: N.7, R.9, F.16, P.26, W.28, F.31, Y.38, P.39, L.41, R.47, I.49, H.50, S.51, Y.52, H.55, W.57 Ligands: DMS.2 25 PLIP interactions: 16 interactions with chain B, 9 interactions with chain A Hydrophobic interactions: B:W.28, B:W.28, B:Y.38, B:P.39, B:I.49, B:Y.52, B:W.57, A:L.40, A:L.46, A:L.84, A:F.91 Hydrogen bonds: B:Y.38, B:R.47, B:H.50, B:S.51, B:Y.52, B:Y.52, B:H.55, A:Y.49, A:N.92, A:N.92 Water bridges: B:H.55 pi-Stacking: B:Y.38, A:F.37 Halogen bonds: A:N.92

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.2: 5 residues within 4Å: Chain A: L.97 Chain B: R.48, I.49, H.50 Ligands: FWZ.1 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:H.50, B:H.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Farnaby, W. et al., BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat.Chem.Biol. (2019)

Release Date

2019-06-12

Peptides

Transcription activator BRG1: A
von Hippel-Lindau disease tumor suppressor: B
Elongin-C: C
Elongin-B: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Transcription activator BRG1

von Hippel-Lindau disease tumor suppressor

Elongin-C

Elongin-B

Related Entries With Identical Sequence